Stemgenics, Inc logo — company profile

Stemgenics, Inc

Founded 2008 2 employees Series Unknown Total: $3.53M Biotechnology, Health and Wellness +1

General Information

Company Name Stemgenics, Inc
Founded Year 2008
Employees 2
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Stemgenics, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stemgenics, Inc

Stemgenics, Inc is a biotechnology, health and wellness, and pharmaceutical startup founded in 2008. The company has developed innovative technology that can convert mature cells, such as skin cells, into personalized stem cells. These Personalized Stem Cells have the potential to regenerate various human body tissues, making them valuable for regenerative medicine. The process involves using proprietary functionalized nanoparticles to reprogram the skin cells into stem cells, without the use of DNA or viruses. As a result, the integrity of the genome in these personalized stem cells remains intact and applicable for human use. One of the key advantages of Stemgenics' technology is the efficient generation of stem cells, ensuring that substantial quantities are readily available for use in regenerative medicine. Importantly, the created stem cells can be used without the risk of rejection or eliciting an immune response. Stemgenics recently received a $445.00K Venture Round investment on 20 June 2018, indicating continued interest and support from investors in the potential of their technology. Despite the absence of specific information about the investor behind the recent investment, Stemgenics stands out as an intriguing player at the intersection of biotechnology and regenerative medicine, offering a promising avenue for potential growth and development.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 20 Jun 2018
Venture Round •••••• - 14 Jan 2016
Venture Round •••••• - 03 Jan 2014
Grant •••••• 1
Investor
28 Jun 2012

Stemgenics, Inc Alternatives & Competitors

Stemgenics, Inc vs

Lifebank by Celularity - the only company that offers cord blood and placental stem cell banking.

11-50 employees
Biotechnology, Care Economy
Stemgenics, Inc vs

#unicocell#unicocell biomed#Integrity #Grit #Quality #Science

12 employees
Health Care, Manufacturing
Stemgenics, Inc vs
Universal Cells
Universal Cells United States

Universal Cells Inc. is a private biotechnology company based in Seattle, Washington that is enablin...

Debt Financing
70 employees
Biotechnology, Health Care

FAQ About Stemgenics, Inc

Stemgenics has developed a breakthrough technology that converts mature cells (skin cells) into personalized stem cells. Stemgenics Personalized Stem Cells may be used to regenerate a variety of tissues of the human body (regenerative medicine). • Cells of a small patch of skin are placed in...
Stemgenics, Inc was founded in 2008.
Stemgenics, Inc operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Stemgenics, Inc has approximately 2 employees.
Stemgenics, Inc has completed 4 funding rounds, raising a total of $3.53M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Stemgenics, Inc include Lifebank Stem Cell Banking, 向榮生技UnicoCell Biomed, Universal Cells, RegenerAge® Elite Clinic | Regenerative Medicine, Acorn Biolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stemgenics, Inc and Lifebank Stem Cell Banking are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stemgenics, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy